Kitajima, K., Igeta, M., Kuyama, J., Kawahara, T., Suga, T., Otani, T., . . . Yamakado, K. (2023). Novel nomogram developed for determining suitability of metastatic castration-resistant prostate cancer patients to receive maximum benefit from radium-223 dichloride treatment—Japanese Ra-223 Therapy in Prostate Cancer using Bone Scan Index (J-RAP-BSI) Trial. European Journal of Nuclear Medicine & Molecular Imaging, 50(5), 1487-1499.
Copiado correctamente al portapapeles
Error al copiar al portapapeles
Cita Chicago Style (17a ed.)
Kitajima, Kazuhiro, et al. "Novel Nomogram Developed for Determining Suitability of Metastatic Castration-resistant Prostate Cancer Patients to Receive Maximum Benefit from Radium-223 Dichloride Treatment—Japanese Ra-223 Therapy in Prostate Cancer Using Bone Scan Index (J-RAP-BSI) Trial."
European Journal of Nuclear Medicine & Molecular Imaging 50, no. 5 (2023): 1487-1499.
Copiado correctamente al portapapeles
Error al copiar al portapapeles
Cita MLA (9a ed.)
Kitajima, Kazuhiro, et al. "Novel Nomogram Developed for Determining Suitability of Metastatic Castration-resistant Prostate Cancer Patients to Receive Maximum Benefit from Radium-223 Dichloride Treatment—Japanese Ra-223 Therapy in Prostate Cancer Using Bone Scan Index (J-RAP-BSI) Trial."
European Journal of Nuclear Medicine & Molecular Imaging, vol. 50, no. 5, 2023, pp. 1487-1499.
Copiado correctamente al portapapeles
Error al copiar al portapapeles
Precaución: Estas citas no son 100% exactas.